THE
Malaysian healthcare system appears successful in delivering good health
outcomes at a reasonable cost.
However,
despite accolades from international bodies, such as the World Health
Organisation, the chief problem in the Malaysian healthcare system, which has
yet to receive adequate attention from the government, is quality.
Patients
complain about long waits, a lack of explanation or “informed consent”
procedures and poor physical facilities.
More
sources of concern are weaknesses in professional standards, inadequate
continuing medical education and lack of quality control, especially in the
private sector, despite laws and regulation governing them.
Within
this context, a successful health system has three attributes: healthy people
(a population that attains the highest level of health possible), superior care
(care that is effective, safe, timely, patient-centred, equitable and
efficient) and fairness (treatment is applied without discrimination or
disparity to all, regardless of age, group identity or place and that the
system is fair to the health professionals, institutions and businesses
supporting and delivering care).
A
sustainable health system also has three key attributes: affordability (for
patients and families, employers, and the government), acceptability (to key
constituents, including patients and health professionals) and adaptability
(that is, a health system must respond adaptively to new diseases, changing
demographics, scientific discoveries and dynamic technologies to remain
viable).
In many
health systems around the globe, primary-care physicians (general
practitioners, or GPs) play a central role as gatekeepers to the rest of the
system. In Malaysia, GPs work mainly in private practice, receiving
fee-for-service payments.
Similarly,
a majority of Malaysian GPs derive a substantial proportion of their income
from dispensing medication to patients, and they are the major obstacle to the
implementation of the separation in dispensing between a GP clinic and a
community pharmacist.
The
Malaysian healthcare is not linked to a private provider or group of providers.
Such a fragmented system needs to be reformed to improve efficiency and safety.
We live in a time when consumers and patients want to know more about the food
they consume and the drugs they take, and their appetite for information is
growing.
Yet the
nation is also facing a communication gap that has implications on public
health. This gap extends from what patients want to know about their medicines.
Evidence
from local and international studies suggests that inadequate communication
about drugs is one reason why 30 to 55 per cent of patients deviate from their
medical regimens.
Patients’
misunderstanding of the use of medication is also an underlying cause of
adverse drug reactions.
The
expansion of the pharmacist’s obligation to inform patients has been
acknowledged in the pharmacists’ code of ethics.
So far,
however, economic considerations and constraints on physicians’ time have
hampered efforts to ensure that patients receive such counselling.
Although
the amount of time physicians can spend discussing medications with patients is
limited, the medical profession has traditionally been committed to patient
education.
There are
relatively few barriers to healthcare providers outlining to patients the risks
of prescribed drugs. The question, therefore, is not one of principle but of
implementation.
Physicians,
not through untrained dispensers, need to re-examine the amount of information
they must give to patients and the way to deliver it. In addition, GPs need to
acknowledge that pharmacists should have a larger role in patient
medicine-related education and advise patients to expect counselling when they
fill their prescriptions for medicines.
Although
the cooperation of many groups is important, the pivotal role, and primary
responsibility for the use of drugs, belongs to the physician and pharmacist.
Their involvement will determine whether a renewed patient-education campaign
will make a difference in public health.
Prof Dr
Mohamed Azmi Ahmad Hassali
Professor of social and administrative
pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang
No comments:
Post a Comment